IGMS240517C10000
- 0.40
- 0.000.00%
IGM Biosciences Newsroom
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI) fell sharply during Monday's session after the company priced a $1.7 million public offering of 8.5 million shares of common stock at $0.20 per share.
IGM Biosciences Inc (IGMS) Q1 2024 Earnings: Aligns With EPS Projections Amidst Clinical ...
Express News | Wedbush Reiterates Outperform on IGM Biosciences, Maintains $20 Price Target
IGM Biosciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 119.3% Wedbush → $20 Reiterates Outperform → Outperform 04/18/2024 31.58% HC Wainwright & Co. →
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), IGM Biosciences (IGMS) and Elanco Animal Health (ELAN)
Express News | IGM Biosciences Inc : RBC Cuts Target Price to $20 From $21
IGM Biosciences Q1 EPS $(0.83), Inline, Sales $497.00K Miss $760.00K Estimate
IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(0.83) per share which met the analyst consensus estimate. This is a 37.59 percent increase over losses of $(1.33) per share from the same p
IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates
Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000
04:42 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000
Express News | IGM Biosciences Inc - Expects to End 2024 With Balance of $180 Million in Cash and Investments
Express News | IGM Biosciences - as a Result of Refocusing of Sanofi Collaboration Announced in April, Expects to Recognize FY Collaboration Revenue of $63 Mln
Express News | IGM Biosciences Inc - Expects Full Year 2024 Gaap Operating Expenses of $210 Million to $220 Million
IGM Biosciences | 10-Q: Quarterly report
Express News | IGM Biosciences Q1 Operating Income USD -53.856 Million
Express News | IGM Biosciences Q1 Collaboration Revenue USD 497 Thousand
Express News | IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
Express News | IGM Biosciences Q1 Operating Expenses USD 54.353 Million
Express News | IGM Biosciences Q1 Basic EPS USD -0.83
Express News | IGM Biosciences Q1 Net Income USD -49.816 Million
Express News | IGM Biosciences Q1 Pretax Profit USD -49.816 Million